Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Temps réel estimé 09:01:52 01/09/2026 Varia. 5j. Varia. 1 janv.
1 859,00 GBX +0,30% Graphique intraday de GSK plc -3,39% +1,59%

Autres langues

08:59 UK house prices subdued; Bunzl lifts outlook
08:43 GSK Plans Late-stage Trial for Flu Vaccine After Positive Phase 2 Results
08:40 GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial
08:12 GSK to advance mRNA flu vaccine to late-stage trial
27/08 FTSE down as inflation fear offsets Nvidia lift
27/08 European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading
26/08 GSK's ViiV Healthcare Says US FDA Approves Tivicay PD for Pediatric HIV Patients
24/08 FTSE 100 outperforms as oil price heads lower
24/08 European Stocks Close Mostly Lower in Monday Trading; US Treasury Secretary Scott Bessent to Give Details on Iran Sanctions
24/08 UK's FTSE 100 Rises as US-Iran Conflict Escalates; GSK Declines
24/08 GSK US President sells shares worth USD2.3 million
24/08 Global markets live: Nvidia, Eli Lilly, ExxonMobil, GSK…
24/08 Exchange-Traded Funds, Equity Futures Fall Pre-Bell Monday as Investors Await Details on US Sanctions Against Iran
24/08 GSK plc Announces Jemperli Accepts for Priority Review by US FDA for dMMR/MSI-H Locally Advanced Rectal Cancer
24/08 Gsk plc Announces Approval of Hibsago (Bepirovirsen) in Japan as First Functional Cure for Chronic Hepatitis B
24/08 GSK Obtains First Global Approval for Chronic Hepatitis B Drug Hibsago
24/08 GSK gets hepatitis approval in Japan, fast US review in rectal cancer
24/08 GSK Says Chronic Hepatitis B Treatment Approved in Japan
24/08 GSK Says Jemperli Accepted for Priority Review as Potential Treatment for Rectal Cancer
24/08 GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy
24/08 GSK drug approved in Japan; Tracsis trading in-line
24/08 FDA prüft Darmkrebsmedikament Jemperli von GSK vorrangig
24/08 GSK's Rectal Cancer Drug Jemperli Accepted for Priority Review by FDA
24/08 GSK's Hibsago Wins Japanese Approval for Chronic Hepatitis B Treatment
24/08 US FDA Accepts GSK's Supplemental Application for Rectal Cancer Drug for Priority Review
Aucun résultat pour cette recherche